Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Fidaxomicin in a Patient Population With Problematic Clostridium Difficile Infection

NCT02355938 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT02355938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02355938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Fidaxomicin in a Patient Population With Problematic Clostridium Difficile Infection
Lead sponsor
Baylor College of Medicine
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2014
Completion date
October 31, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile, spinal cord injury